Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

01-12-2020 | Nosocomial Infection | Research

Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis

Authors: Yohann Lacotte, Christine Årdal, Marie-Cécile Ploy, on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI)

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

Background

Infection prevention and control (IPC) is one of the most cost-effective interventions against antimicrobial resistance (AMR). Yet, IPC knowledge gaps often receive little prominence in AMR research agendas. In this article, we construct IPC research priorities, in order to draw attention to these critical research needs.

Methods

We developed a 4-step framework to identify IPC knowledge gaps from literature (narrative review). These gaps were then translated into research priorities and sent to two groups of European IPC experts for validation and critique through an online survey.

Results

Seventy-nine publications were retrieved from the literature review, identifying fifteen IPC research gaps. Forty-four IPC experts, clustered in two groups, vetted them. The experts classified all research gaps as medium or high priority. Overall agreement between both groups was average (Kendall’s τ = 0.43), with strong alignment on the highest priorities: (i) the assessment of organizational, socio-economic, and behavioural barriers/facilitators for the implementation of IPC programmes, (ii) the impact of overcrowding on the spread of infections and (iii) the impact of infrastructural changes, at facility level, on the reduction of infections. Feedback from experts also identified an additional research gap on the interaction between the human and hospital microbiomes.

Conclusions

We formulated a list of sixteen research priorities and identified three urgent needs. Now, we encourage researchers, funding agencies, policymakers and relevant stakeholders to start addressing the identified gaps.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.CrossRefPubMedPubMedCentral Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.CrossRefPubMedPubMedCentral
3.
go back to reference Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016;387(10015):296–307.CrossRefPubMed Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016;387(10015):296–307.CrossRefPubMed
4.
go back to reference SA ME, Collignon PJ. Antimicrobial Resistance: a One Health Perspective. Microbiology Spectrum. 2018;6:2. SA ME, Collignon PJ. Antimicrobial Resistance: a One Health Perspective. Microbiology Spectrum. 2018;6:2.
5.
go back to reference van Hengel AJ, Marin L. Research, innovation, and policy: an Alliance combating antimicrobial resistance. Trends Microbiol. 2019;27(4):287–9.CrossRefPubMed van Hengel AJ, Marin L. Research, innovation, and policy: an Alliance combating antimicrobial resistance. Trends Microbiol. 2019;27(4):287–9.CrossRefPubMed
10.
go back to reference Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank H-P, Ducomble T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based Modelling study. PLoS Med. 2016;13(10):e1002150.CrossRefPubMedPubMedCentral Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank H-P, Ducomble T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based Modelling study. PLoS Med. 2016;13(10):e1002150.CrossRefPubMedPubMedCentral
12.
go back to reference Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery. 2017;152(8):784–91.CrossRefPubMed Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery. 2017;152(8):784–91.CrossRefPubMed
14.
go back to reference Hoelzer K, Bielke L, Blake DP, Cox E, Cutting SM, Devriendt B, et al. Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs. Veterinary Research. 2018;49(1):64.CrossRefPubMedPubMedCentral Hoelzer K, Bielke L, Blake DP, Cox E, Cutting SM, Devriendt B, et al. Vaccines as alternatives to antibiotics for food producing animals. Part 1: challenges and needs. Veterinary Research. 2018;49(1):64.CrossRefPubMedPubMedCentral
15.
go back to reference Gao Z, Kang Y, Yu J, Ren L. Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genom Proteomics Bioinformatics. 2014;12(3):144–50.CrossRef Gao Z, Kang Y, Yu J, Ren L. Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genom Proteomics Bioinformatics. 2014;12(3):144–50.CrossRef
16.
go back to reference Yoon MY, Lee K, Yoon SS. Protective role of gut commensal microbes against intestinal infections. J Microbiol. 2014;52(12):983–9.CrossRefPubMed Yoon MY, Lee K, Yoon SS. Protective role of gut commensal microbes against intestinal infections. J Microbiol. 2014;52(12):983–9.CrossRefPubMed
17.
go back to reference Pettigrew MM, Johnson JK, Harris AD. The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol. 2016;26(5):342–7.CrossRefPubMedPubMedCentral Pettigrew MM, Johnson JK, Harris AD. The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance. Ann Epidemiol. 2016;26(5):342–7.CrossRefPubMedPubMedCentral
18.
go back to reference Marme G. Barriers and facilitators to effective tuberculosis infection control practices in Madang Province, PNG - A qualitative study. Rural Remote Health. 2018;18:4401.PubMed Marme G. Barriers and facilitators to effective tuberculosis infection control practices in Madang Province, PNG - A qualitative study. Rural Remote Health. 2018;18:4401.PubMed
19.
go back to reference Le CD, Lehman EB, Nguyen TH, Craig TJ. Hand hygiene compliance study at a large central Hospital in Vietnam. Int J Environ Res Public Health. 2019;16(4):607.CrossRefPubMedCentral Le CD, Lehman EB, Nguyen TH, Craig TJ. Hand hygiene compliance study at a large central Hospital in Vietnam. Int J Environ Res Public Health. 2019;16(4):607.CrossRefPubMedCentral
20.
go back to reference Mitchell KF, Barker AK, Abad CL, Safdar N. Infection control at an urban hospital in Manila, Philippines: a systems engineering assessment of barriers and facilitators. Antimicrob Resist Infect Control. 2017;6:90.CrossRefPubMedPubMedCentral Mitchell KF, Barker AK, Abad CL, Safdar N. Infection control at an urban hospital in Manila, Philippines: a systems engineering assessment of barriers and facilitators. Antimicrob Resist Infect Control. 2017;6:90.CrossRefPubMedPubMedCentral
21.
go back to reference Troughton R, Mariano V, Campbell A, Hettiaratchy S, Holmes A, Birgand G. Understanding determinants of infection control practices in surgery: the role of shared ownership and team hierarchy. Antimicrobial Resistance Infection Control. 2019;8(1):116.CrossRefPubMedPubMedCentral Troughton R, Mariano V, Campbell A, Hettiaratchy S, Holmes A, Birgand G. Understanding determinants of infection control practices in surgery: the role of shared ownership and team hierarchy. Antimicrobial Resistance Infection Control. 2019;8(1):116.CrossRefPubMedPubMedCentral
22.
go back to reference Saint S, Kowalski CP, Banaszak-Holl J, Forman J, Damschroder L, Krein SL. The Importance of Leadership in Preventing Healthcare-Associated Infection: Results of a Multisite Qualitative Study. Infect Control Hospital Epidemiol. 2015. 2010;31(9):901–7.CrossRef Saint S, Kowalski CP, Banaszak-Holl J, Forman J, Damschroder L, Krein SL. The Importance of Leadership in Preventing Healthcare-Associated Infection: Results of a Multisite Qualitative Study. Infect Control Hospital Epidemiol. 2015. 2010;31(9):901–7.CrossRef
23.
go back to reference Gilbert GL, Kerridge I. The politics and ethics of hospital infection prevention and control: a qualitative case study of senior clinicians’ perceptions of professional and cultural factors that influence doctors’ attitudes and practices in a large Australian hospital. BMC Health Serv Res. 2019;19(1):212.CrossRefPubMedPubMedCentral Gilbert GL, Kerridge I. The politics and ethics of hospital infection prevention and control: a qualitative case study of senior clinicians’ perceptions of professional and cultural factors that influence doctors’ attitudes and practices in a large Australian hospital. BMC Health Serv Res. 2019;19(1):212.CrossRefPubMedPubMedCentral
24.
go back to reference Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, et al. Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis. 2015;15(2):212–24.CrossRefPubMed Zingg W, Holmes A, Dettenkofer M, Goetting T, Secci F, Clack L, et al. Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus. Lancet Infect Dis. 2015;15(2):212–24.CrossRefPubMed
25.
go back to reference Mitchell BG, Gardner A, Stone PW, Hall L, Pogorzelska-Maziarz M. Hospital staffing and health care–associated infections: a systematic review of the literature. Jt Comm J Qual Patient Saf. 2018;44(10):613–22.PubMed Mitchell BG, Gardner A, Stone PW, Hall L, Pogorzelska-Maziarz M. Hospital staffing and health care–associated infections: a systematic review of the literature. Jt Comm J Qual Patient Saf. 2018;44(10):613–22.PubMed
26.
go back to reference Driscoll A, Grant MJ, Carroll D, Dalton S, Deaton C, Jones I, et al. The effect of nurse-to-patient ratios on nurse-sensitive patient outcomes in acute specialist units: a systematic review and meta-analysis. Eur J Cardiovasc Nurs. 2017;17(1):6–22.CrossRefPubMed Driscoll A, Grant MJ, Carroll D, Dalton S, Deaton C, Jones I, et al. The effect of nurse-to-patient ratios on nurse-sensitive patient outcomes in acute specialist units: a systematic review and meta-analysis. Eur J Cardiovasc Nurs. 2017;17(1):6–22.CrossRefPubMed
27.
go back to reference Ahyow LC, Lambert PC, Jenkins DR, Neal KR, Tobin M. Bed occupancy rates and hospital-acquired Clostridium difficile infection: a cohort study. Infect Control Hosp Epidemiol. 2013;34(10):1062–9.CrossRefPubMed Ahyow LC, Lambert PC, Jenkins DR, Neal KR, Tobin M. Bed occupancy rates and hospital-acquired Clostridium difficile infection: a cohort study. Infect Control Hosp Epidemiol. 2013;34(10):1062–9.CrossRefPubMed
28.
go back to reference Abir M, Goldstick J, Malsberger R, Setodji CM, Dev S, Wenger N. The Association of Inpatient Occupancy with hospital-acquired Clostridium difficile infection. J Hosp Med. 2018;13(10):698–701.PubMed Abir M, Goldstick J, Malsberger R, Setodji CM, Dev S, Wenger N. The Association of Inpatient Occupancy with hospital-acquired Clostridium difficile infection. J Hosp Med. 2018;13(10):698–701.PubMed
29.
go back to reference Schwab F, Meyer E, Geffers C, Gastmeier P. Understaffing, overcrowding, inappropriate nurse:ventilated patient ratio and nosocomial infections: which parameter is the best reflection of deficits? J Hosp Infect. 2012;80(2):133–9.CrossRefPubMed Schwab F, Meyer E, Geffers C, Gastmeier P. Understaffing, overcrowding, inappropriate nurse:ventilated patient ratio and nosocomial infections: which parameter is the best reflection of deficits? J Hosp Infect. 2012;80(2):133–9.CrossRefPubMed
30.
go back to reference Goldstein ND, Ingraham BC, Eppes SC, Drees M, Paul DA. Assessing occupancy and its relation to healthcare-associated infections. Infect Control Hosp Epidemiol. 2017;38(1):112–4.CrossRefPubMed Goldstein ND, Ingraham BC, Eppes SC, Drees M, Paul DA. Assessing occupancy and its relation to healthcare-associated infections. Infect Control Hosp Epidemiol. 2017;38(1):112–4.CrossRefPubMed
31.
go back to reference Stiller A, Salm F, Bischoff P, Gastmeier P. Relationship between hospital ward design and healthcare-associated infection rates: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2016;5:51.CrossRefPubMedPubMedCentral Stiller A, Salm F, Bischoff P, Gastmeier P. Relationship between hospital ward design and healthcare-associated infection rates: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2016;5:51.CrossRefPubMedPubMedCentral
34.
go back to reference Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.CrossRefPubMedPubMedCentral Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.CrossRefPubMedPubMedCentral
36.
go back to reference Szymczak JE. Beyond barriers and facilitators: the central role of practical knowledge and informal networks in implementing infection prevention interventions. BMJ Qual Saf. 2018;27(10):763.CrossRefPubMed Szymczak JE. Beyond barriers and facilitators: the central role of practical knowledge and informal networks in implementing infection prevention interventions. BMJ Qual Saf. 2018;27(10):763.CrossRefPubMed
37.
go back to reference Clack L, Zingg W, Saint S, Casillas A, Touveneau S, da Liberdade JF, et al. Implementing infection prevention practices across European hospitals: an in-depth qualitative assessment. BMJ Qual Saf. 2018;27(10):771.CrossRefPubMedPubMedCentral Clack L, Zingg W, Saint S, Casillas A, Touveneau S, da Liberdade JF, et al. Implementing infection prevention practices across European hospitals: an in-depth qualitative assessment. BMJ Qual Saf. 2018;27(10):771.CrossRefPubMedPubMedCentral
38.
go back to reference Sim J, Wright C. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.CrossRefPubMed Sim J, Wright C. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.CrossRefPubMed
Metadata
Title
Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis
Authors
Yohann Lacotte
Christine Årdal
Marie-Cécile Ploy
on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI)
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-020-00801-x

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.